Axsome Therapeutics, Inc. carries a market capitalization of 12.06B, placing it among publicly traded companies globally.
| Market Cap | 12.06B |
| Enterprise Value | N/A |
Axsome Therapeutics, Inc.'s stock has gained approximately 122.29074% over the past 52 weeks. The 50-day moving average sits at 85.35, while the 200-day moving average is 75.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | 122.29074% |
| 50-Day Moving Average | 85.35 |
| 200-Day Moving Average | 75.30 |
| Average Volume (20 Days) | N/A |